Insulin hypoglycaemia provides a glycopenic stimulus producing a vagal gastric secretory response (Jogi, Strom, and Uvnas, 1949). Earlier investigators (Hollander, Jemerin, and Weinstein, 1942; Davis, Brooks, and Robert, 1965) believed that the gastric acid response to insulin hypoglycaemia represented an 'all-or-none' phenomenon which was (1) initiated when the blood glucose fell to a given threshold value and (2) not related to the degree of hypoglycaemia below such a threshold. The recent finding, however, of a quantitative relationship between insulin dose, hypoglycaemia, and acid secretion (Baron, 1970; Spencer and Grossman, 1971) does not support the 'all-or-none' hypothesis.
Insulin hypoglycaemia provides a glycopenic stimulus producing a vagal gastric secretory response (Jogi, Strom, and Uvnas, 1949) . Earlier investigators (Hollander, Jemerin, and Weinstein, 1942; Davis, Brooks, and Robert, 1965) believed that the gastric acid response to insulin hypoglycaemia represented an 'all-or-none' phenomenon which was (1) initiated when the blood glucose fell to a given threshold value and (2) not related to the degree of hypoglycaemia below such a threshold. The recent finding, however, of a quantitative relationship between insulin dose, hypoglycaemia, and acid secretion (Baron, 1970; Spencer and Grossman, 1971) does not support the 'all-or-none' hypothesis.
A single rapid intravenous injection of insulin, such as used by the previously mentioned workers, produces a nadir of hypoglycaemia with gradual restoration of normoglycaemia. In human subjects (Carter, Dozois, and Kirkpatrick, 1972) an infusion of insulin provides a steady level of hypoglycaemia which, if reproducible in the dog, should facilitate correlation studies between blood glucose changes and gastric acid changes.
The present investigation was undertaken to study the effect of a continuous infusion of insulin on the blood glucose response in the dog and to establish the relationship between insulin dose, degree of hypoglycaemia, and acid response. 
Methods
Four mongrel male dogs, 10 to 14 kg in weight, were each surgically provided with a chronic gastric fistula (Thomas, 1941 60, 90, 120 , and 150 minutes after the start of the infusion and expressed in mg/100 ml; (2) the lowest blood glucose (LBG), being the lowest blood glucose value observed during the insulin infusion, expressed in mg/100 ml; and (3) the Al blood glucose (A BG), being the difference between the initial fasting blood glucose and the plateau blood glucose, expressed as a percentage of the fasting blood glucose.
With regard to acid secretion, two variables were examined: (1) the peak acid output (PAO), calculated as the sum of the two highest consecutive 15-minute collections during the infusion, multiplied by 2 and expressed as m-equiv/hr (Baron, 1963) ; (2) (0) The mean secretory responses to the insulin infusion in all tests are shown in figure 3. Low basal outputs of acid were constantly observed and no initial inhibition of acid secretion following the start of the infusion could be detected. In each test in each of the four dogs and with every dose of insulin tested, a delay in the onset of the acid response was observed. This delay varied between dogs for each dose, but was dose-related in that progressively shorter delays were noted with increasing doses of insulin, up to 015 u/kg hr (fig 3) .
Following this initial delay in the onset of acid secretion, the acid output rapidly increased. With the lowest dose of insulin capable of initiating acid secretion (0-025 u/kg hr for dogs B and D and 0.05 u/kg hr for dogs A and C), the output of acid tended to follow a plateau for the duration of the test. With the higher doses, a peak was reached after which the acid output declined in a stepwise fashion for the (table II, fig 6) . The A BG also correlated significantly with the PAO in all dogs and with the TAO in all but one of the animals (table II) .
Discussion
Our results indicate that insulin provides a quantitative glycopenic stimulus producing a quantitative vagal acid response, thus refuting the 'all-or-none' hypothesis.
In contrast to the single intravenous injection which produces a nadir of hypoglycaemia with a gradual return to normoglycaemic levels, the insulin infusion results in a prolonged 'plateau' of hypoglycaemia. The concept of an insulin infusion is not entirely new (Demand, Gross, and Berg, 1968; Carter et al, 1972) and we have observed a similar pattern of blood glucose response in healthy human subjects (Carter et al, 1972) . Larger doses of insulin administered as a single injection will also tend to prolong the period of hypoglycaemia (Spencer and Grossman, 1971) . In our experiments, graded doses of insulin up to 0-15 u/kg hr produced graded levels of hypoglycaemia.
Similarly, graded doses of insulin resulted in a graded acid response. Such findings have been reported in man (Baron, 1970; Isenberg, Stening, Ward, and Grossman, 1969) , in the dog (Cooke, 1969; Spencer and Grossman, 1971) , and in the cat (Stening and Isenberg, 1969) , where insulin was administered as a single intravenous injection.
The infusion of insulin produced a steady level of hypoglycaemia, but a peak rather than a plateau of acid secretion was observed with larger doses of insulin. Such findings would indicate that the acid response, initiated by the fall in blood glucose or the nadir, is not sustained by prolongation of the period of hypoglycaemia and that this phenomenon could be dose-dependent. Persistent hypoglycaemia would appear to provide a continuous glycopenic stimulus since lower doses of insulin tended to produce a steady state of acid secretion. However, prolonged hypoglycaemia due to larger doses of insulin may be concomitantly associated with important and persistent inhibition of acid secretion. This is suggested by the observation that the largest two doses of insulin used in our experiments produced peak acid outputs of comparable magnitude while the subsequent decline in acid secretion was consistently steeper and more important with the largest dose. Work is in progress to determine if changes in potassium levels are responsible for this phenomenon. In man, blood glucose values of less than 15 mg/100 ml were associated with inhibition of gastric acid secretion (Baron, 1970) . In the dog, blood 'sugar' values of less than 25 mg/100 ml have been reported to be associated with inhibition of gastric acid secretion (Necheles, Olson, and Scruggs, 1942) and of pancreatic (Scott, Collignon, Bugel, and Johnson, 1941) and intestinal secretion (Kneller and Nasset, 1949) . There was, however, a definite quantitative relationship between the insulin dose, the degree of hypoglycaemia, and the magnitude of the acid response.
No initial inhibitory phase of acid secretion could be detected following the start of the insulin infusion. This is contrary to previous workers' findings (Olson and Necheles, 1955) who used insulin preparations 'contaminated' with glucagon, which might have been responsible for such an effect (Aylett, 1962) , but is in agreement with Spencer and Grossman's findings (1971) who used, like us, purified insulin. Insulin is by itself, however, a powerful inhibitor of histamine- (Hirschowitz and Robbins, 1966) and pentagastrin- (Hirschowitz and Sachs, 1972) induced acid secretion. In our tests, a delay in the onset of the acid response was consistently seen following the commencement of the infusion. Such delay appeared to be dose-related in that shorter delays were observed with larger doses of insulin.
